NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Jan 8, 2026
- Closes
- Sep 3, 2026 (in 21 days)
Similar opportunities open now
- INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jun 2028Up to $500K
- Research Grants in Clinical Informatics (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2029Up to $250K
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2029Up to $250K
- NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 4 daysUp to $475K
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)OpenNational Institutes of HealthCloses Apr 2029
Classification and identifiers
- Solicitation number
- RFA-RM-27-003
- Assistance listing (CFDA)
- 93.310
Amount
Amount not published by the funder
Who can apply
Private colleges and universities, Nonprofits, including small and volunteer-run organizations, Public colleges and universities, and State government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
The NIH Director"s Transformative Research Award supports individual scientists or groups of scientists proposing bold, groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in a broad area of relevance to the NIH. The NIH Director"s Transformative Research Award is a component of the High-Risk, High-Reward Research (HRHR) program ...
Related opportunities
- INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Jun 2028Up to $500K
- Research Grants in Clinical Informatics (R01 Clinical Trial Optional)National Institutes of HealthCloses Mar 2029Up to $250K
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)National Institutes of HealthCloses Mar 2029Up to $250K
- NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)National Institutes of HealthCloses in 4 daysUp to $475K
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)National Institutes of HealthCloses Apr 2029